Polypeptide based formulations that undergo liquid to hydrogel transitions upon change in temperature have become desirable targets since they can be mixed with cells or injected into tissues as liquids, and subsequently transform into rigid scaffolds or depots.
Introduction
Synthetic hydrogels have received much attention in recent years due to their inherent similarities to biological materials such as extracellular matrix. 1, 2 In order to successfully mimic the properties of complex natural materials, and for optimization of properties for potential applications in regenerative medicine and therapeutic delivery, it is desirable that synthetic hydrogels replicate both the structural properties and chemical functionality found in natural hydrogels. These features may include stimulus responsive mechanical properties as well as the incorporation of bioactive and biodegradable components. 3 Polypeptides are excellent candidates for synthesis of biomimetic hydrogels since they are enzymatically degradable, can include a wide range of chemical functionality, and they adopt ordered conformations that can drive structure formation and also respond to stimuli. 4 In particular, polypeptide formulations that undergo liquid to hydrogel transitions upon change in temperature have become desirable targets since they can be mixed with cells or injected into tissues as liquids, and subsequently transform into rigid scaffolds or depots.
Previous examples of thermoresponsive hydrogels based solely on polypeptides have all been created from protein polymers produced biosynthetically in microorganisms.
In 1998, Tirrell reported protein based triblock copolymers that formed hydrogels via coiled-coil assembly of terminal α-helical domains, where these domains could be reversibly disassembled to yield liquids at elevated temperatures. 5 Triblock protein copolymers were also prepared using elastin mimetic domains designed so that the central domain is water-soluble and the terminal domains have solubility that changes with temperature. 6, 7 Due to the thermoresponsive behavior of the terminal domains, these materials undergo reversible liquid to hydrogel transitions as temperature is increased.
Gelation in both designs occurs mainly due to temperature dependent interchain assembly driven primarily via hydrophobic interactions, which allows good reversibility. Replication of these properties in synthetic polypeptide hydrogels is desirable since it may allow more facile tunability of physical properties, which is of particular importance for in vivo applications where synthetic materials avoid the potential drawbacks of immunogenicity and pathogen contamination that can occur with proteins isolated from mammalian sources. 4 The preparation of thermoresponsive hydrogels based solely on synthetic polypeptides has been challenging, and has only been demonstrated using small, sequencespecific peptides under certain conditions. 8 The closest polypeptide containing examples are based on hybrid block copolymers, where a nondegradable segment, usually polyethylene oxide, PEO, is connected to a polypeptide segment. 3, [9] [10] [11] [12] Hydrogel formation is driven by dehydration of the PEO segments as temperature increased, as well as use of short polypeptide segments able to transition to β-sheet rich conformations at elevated temperatures. The β-sheet structures stabilize hydrogel formation via interchain H-bonding, but also lead to irreversibility of the liquid to hydrogel transition. 3, 12, 13 These materials typically show transitions over broad temperature ranges and transition temperatures that vary greatly with sample concentration. 3, 9, 10, 12 Recently, Li developed ethylene oxide sidechain modified polypeptides that are themselves thermoresponsive, and found that these can also form thermoresponsive hydrogels as diblock copolymers with PEO. 13, 14 These materials formed weak hydrogels at 20 ºC that increased in stiffness at elevated temperatures due to PEO dehydration and formation of β-sheet structures. Although much progress has been made in this area, there are currently no reversible, thermoresponsive hydrogels based solely on synthetic polypeptide components.
For many years, our lab has prepared and studied synthetic block copolypeptide hydrogels (DCH), which are soft hydrogels composed of discrete ionic and hydrophobic polypeptide segments that can be adjusted to allow a high level of control over gel stiffness, gel porosity, gel functionality and media stability. [15] [16] [17] [18] DCH are physically associated gels composed of branched and tangled self-assembled fibrils that can be deformed by applied stress and injected through small-bore cannulae, after which they rapidly re-assemble into rigid gel networks. 16 When injected into mouse central nervous system (CNS) tissues, ionic DCH self-assemble into discrete, well formed deposits of rigid gel networks in vivo that integrate well with host CNS tissue, causing no detectable toxicity or adverse inflammatory reaction, and are fully degraded after several months in vivo. 19 We also reported both in vitro and in vivo evidence that ionic DCH can serve as depots for sustained local release of both hydrophilic and hydrophobic effector molecules for investigative and potential therapeutic applications in the CNS. 20, 21 Ionic DCH have many advantageous properties as biomimetic hydrogels, yet lack thermoresponsive properties 5 that would be beneficial for supporting the survival of suspended cells and for use as vehicles for cell transplantation.
The goal of the present study was to extend the capabilities of DCH in two ways by developing DCH that are non-ionic and that also incorporate thermoresponsive behavior.
Initial experiments using our traditional ionic DCH compositions, K 180 L 20 and E 180 L 20 ,
showed that these highly charged DCH were prohibitively cytotoxic to cell suspensions in vitro (vide infra). We realized that DCH needed to be redesigned to improve their cell compatibility, and focused our efforts first on the development of non-ionic DCH, named DCH EO , since non-ionic polymers and hydrogels are well known to be less toxic to cells in vitro 1, 22 . We also report on the design and successful incorporation of α-helical copolypeptide domains into DCH EO that give rise to thermoresponsive DCH, named DCH T .
These new α-helical segments in DCH T were found to provide excellent tunability of physical properties and allow completely reversible liquid to hydrogel transitions between room temperature and body temperature in a variety of media. DCH T were also found to successfully support survival of encapsulated cells in vitro.
Experimental Section
Materials and instrumentation Tetrahydrofuran (THF), hexanes, and methylene chloride were dried by purging with nitrogen and passage through activated alumina columns prior to use. Co(PMe 3 ) 4 and amino acid N-carboxyanhydride (NCA) monomers were prepared according to literature procedures. 16, 23 All other chemicals were purchased from commercial suppliers and used without further purification unless otherwise noted.
Thin-layer chromatography (TLC) was conducted with EMD gel 60 F254 precoated plates (0.25 mm) and visualized using a combination of UV, anisaldehyde, and phosphomolybdic acid staining. Selecto silica gel 60 (particle size 0.032-0.063 mm) was used for flash column chromatography. Fourier Transform Infrared (FTIR) measurements were taken on a Perkin Elmer RX1 FTIR spectrophotometer calibrated using polystyrene film. 1 in THF according to published procedures 16 . All copolymerization reactions were performed in a dinitrogen filled glovebox using anhydrous solvents. Isolated yields of the purified copolymers ranged between 90% and 95%. Relative copolypeptide compositions ( Fig. 1) were determined using 1 H NMR and were found to be within 1% of predicted values. Chain lengths of initial poly(rac-E P2 ) segments were determined using end-capping analysis (see Table S1 , Fig. S1 ) 24 .
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The copolymer was dispersed in DI water and then placed in a dialysis bag (MWCO = 2000 Da) and dialyzed exhaustively against DI water for four days in a sterile container.
Lyophilization of the resulting clear suspension gave 720 mg poly(rac-E P2 ) 180 -block-
0.5 /L 0.5 ) 30 , (90% yield) as a fluffy white solid. 1 H NMR analysis of this material was used to determine the actual copolymer composition, which was found to be (rac-E P2 ) 180 (E P2 0.5 /L 0.5 ) 28 (see Table S2 ). 30 polypeptide segment concentration in mg/mL; and l is the cuvette pathlength in cm. The percent α-helical content of the polypeptides was calculated using the formula % α-helix = (-[θ] 222nm +3000)/39000) where [θ] 222nm is the measured molar ellipticity at 222 nm.
Circular Dichroism Studies
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Rheology measurements DCH T were prepared by rehydrating freeze-dried samples in aqueous phosphate buffered saline pH = 7.4 (PBS). Rheological measurements (dynamic) were performed in triplicate on a strain controlled Reometrics fluids spectrometer RFS II in a cone-plate geometry with diameter of 25 mm and cone angle of 0.02 rad similar to previously described. 15 Strain was set at 10% and the sweep frequency was 1 rad/s. For each sample small-deformation linearity was checked before performing oscillatory Gelation temperature (T G ) measurements 0. in dialyzate samples were measured using a calibrated gas chromatography (GC) method. 21 The cholesterol was extracted from an aliquot of dialysate with toluene (0.5 ml x3), and its concentration was quantified using a Shimdazu 6890N gas chromatographic system with a DB-17 capillary column (30 m x 0.250 mm x 0.15 mm, Agilent Technologies Inc., CA, USA). The DB-17 column has mid-polarity and is suitable for analysis of free steroids.
One microliter (1.0 µl) of analyte in toluene was injected into GC system with split/splitless injector and flame ionization detector. The inlet temperature was 250 ºC and the split ratio was 10:1. The carrier gas was helium at 2.5 ml/min constant flow. The oven was programmed to start at 250 ºC, hold for 5 min, followed by increasing temperature at a rate of 5 ºC/min up to 260 ºC, and then hold again for 8 min. The total time for GC analysis was 15 min. The detector was set at 300 ºC with 200 ml/min air flow, 80 ml/min hydrogen flow, and 40 ml/min helium makeup flow. All measurements were performed in triplicate
and average values reported.
Cells for in vitro evaluations of DCH cytotoxicity
The cytotoxicity of the different DCH was evaluated using HeLa cells and murine bone-marrow mesenchymal stem cells (MSCs). The HeLa cell line was maintained using standard tissue culture protocols. 29 MSCs were isolated from 6-to 8-week-old wild type mice. 30 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 added to the cells, which were then transferred to a humidified 5% CO 2 incubator at 37°C for 1 hour. Absorbance at 490 nm (A490) was measured for each well using an Infinite 
Results and Discussion
Rationale and design of non-ionic DCH To evaluate the potential of DCH as cell carriers and vehicles for transplantation, we first examined cell suspensions prepared in conventional ionic DCH and maintained in vitro. We used our well characterized cationic and anionic DCH, K 180 L 20 and E 180 L 20 respectively, which previous studies had shown were well tolerated and caused no detectable cell damage or toxicity when injected as circumscribed deposits into the CNS in vivo. 19, 21, 26 In spite of the lack of toxicity of ionic DCH deposits in vivo, we found that both K 180 L 20 and E 180 L 20 exhibited pronounced and rapid toxicity towards fully immersed suspensions of HeLa cells (see Figure S1 ).
Compared with cells incubated in standard culture media, survival of cells suspended in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 ionic DCH declined steadily and rapidly over time (see Figure S1 ). Toxicity also increased with increasing concentration of ionic DCH (see Figure S1 ). The cationic DCH, K 180 L 20 , was substantially more toxic than the anionic DCH, E 180 L 20 (see Figure S1 ). results in high toxicity. 33 In work on other polypeptide assemblies, such as with vesicles and micelles, we have found that replacement of cationic hydrophilic segments with nonionic hydrophilic segments resulted in materials with minimal in vitro cytotoxicity. 29, 34, 35 We therefore set about redesigning DCH to improve their cell compatibility by focusing our efforts on the development of non-ionic DCH.
Based on previous results, 29, [34] [35] [36] we recognized that a critical requirement of nonionic DCH design strategy would be that candidate non-ionic hydrophilic segments possess disordered chain conformations in order to promote hydrogel formation. We have shown previously that use of ordered hydrophilic segments (i.e. α-helical) in polypeptide assemblies generally results in formation of rigid sheets that will not form hydrogels.
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With this in mind, we chose to utilize poly(γ-[2-(2-methoxyethoxy)ethyl]-rac-glutamate),
(rac-E P2 ), as a hydrophilic segment to prepare non-ionic DCH (Figure 1 ), since this polypeptide is non-ionic, highly water soluble, and possesses a disordered chain conformation due to its racemic residue composition. 23 We prepared diblock copolypeptides containing hydrophilic (rac-E P2 ) and Tables S1 and S2 , Figure S2 ). These samples were found to form hydrogels upon direct dissolution in aqueous media at low concentrations, greater than ca.
2-3 wt%, and were found to possess gel stiffness (storage modulus, G′) that increased with 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13 hydrophobic L segment chain lengths, similar to ionic DCH (see Table S3 ). These results
show that non-ionic poly(rac-E P2 ) is a good surrogate for polyelectrolyte K or E segments, and that the molecular design criteria used for tuning properties of ionic DCH also apply to formation and tuning of non-ionic DCH EO. 18 These features allows the straightforward preparation of non-ionic DCH with tunable properties that should have improved cell compatibility (vide infra), and also retain the desirable characteristics of ionic DCH, such as injectability, tunable rigidity and porosity. were incorporated as additional segments either before or after the hydrophobic L segments of DCH EO type copolypeptides (Figure 1 ). When dispersed in aqueous media, none of these triblock copolypeptide designs displayed the desired thermoresponsive hydrogel formation characteristics, and instead either formed hydrogels or liquids that did not respond to temperature changes ( Figure. 1 samples 2-4, 7) , or formed precipitates when temperature was increased to 40 ºC ( Figure 1 samples 5, 6 ).
In order to better combine the properties of thermosensitive E P2 residues and permanently hydrophobic L residues, we redesigned the copolypeptides as diblock copolymers where equimolar E P2 and L residues were combined together in statistical sequences as single thermoresponsive segments, e.g. poly(γ-[2-(2-methoxyethoxy)ethyl]-
rac-glutamate)-block-poly(γ-[2-(2-methoxyethoxy)ethyl]-L-glutamate-stat-L-leucine),
(rac-E P2 ) 180 (Figure 1 samples 11,12 ). All DCH T samples in Figure 1 formed completely transparent liquids and hydrogels over a temperature range of 4 to 90 ºC when dispersed in aqueous media, and all transitions between liquid and hydrogel states were fully reversible over many heating and cooling cycles. Such reversibility has not been observed in other synthetic polypeptide containing thermoresponsive hydrogels and is likely due to the stable α-helical conformations of the thermoresponsive domains in our samples (see Figure S4 ). Also, in either liquid or gel state, all DCH T (3 wt %) could be injected through 30 Ga needles without difficulty (vide infra), similar to other DCH. 
Tuning properties of DCH T
As noted previously, an advantage of DCH as synthetic biomaterials is the ease with which their physical properties, such as hydrogel stiffness (G′) and porosity, can be predictably, and often independently, adjusted. In DCH T , hydrogel stiffness is readily adjusted by variation of the length of the thermoresponsive segments ( Figure 3A) , where increasing segment length results in increased stiffness above the gelation temperature (T G ). Alternatively, adjustment of DCH T concentration can also be used to tune gel stiffness above T G ( Figure 3B) , and also modify hydrogel porosity. These characteristics of DCH T are similar to properties observed with other ionic DCH, 18 indicating that DCH T are able to incorporate thermoresponsive properties while retaining the other features of DCH. We have also observed that DCH T are able to respond quickly to temperature changes, with rapid formation of rigid hydrogels occurring within seconds of heating above T G .
In addition to the tuning of properties described above, another important parameter to adjust in DCH T samples is their transition temperature T G . For use in biomaterial applications in vivo, it is desirable to fine-tune T G to both control the rate of gel formation and for use in tissues at different temperatures. The temperature of internal tissues in animals will be close to 37 ºC, however, exposed tissues, as would be encountered during a surgery may be at temperatures significantly lower than 37 ºC. We observed that the T G of 3 wt % DCH T sample 9 was ca. 37 ºC in DI water, which may not result in complete gel formation in tissues at or below that temperature. In order to adjust T G in DCH T , we designed new samples where some of the E P2 residues in the thermoresponsive segments in DCH T were replaced with γ-(2-methoxyethyl)-L-glutamate, E P1 , residues ( Figure 1 samples   11,12 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 19 samples 9, 11, and 12 where E P1 content increased from 0 to 20 to 40% of the total E P1 and E P2 present, respectively ( Figure 3C, 3D ). While 40% substitution of E P1 for E P2 in sample 12 resulted in a significant decrease in T G (30.6 ºC) compared to 9 (37.0 ºC), the effect of this substitution on DCH T stiffness (G′) above T G was minimal ( Figure 3C ). These results
show that T G in DCH T can be adjusted essentially independently of hydrogel stiffness. An alternative method to adjust T G in DCH T was also developed, where thermoresponsive DCH T 9 was physically mixed in different proportions in aqueous media with nonthermoresponsive DCH EO 1. These copolypeptide blends were found to possess lower T G compared to 9, with T G decreasing as the fraction of more hydrophobic 1 was increased ( Figure 3D ). This approach utilizes the increased hydrophobicity of DCH EO compared to DCH T to decrease T G in the blends, and is advantageous in that T G can be finely tuned by simply varying the mixing ratio of pre-made 9 and 1. Together, both methods described above provide ample means to fine-tune T G to desired values over a broad temperature range useful for in vivo applications ( Figure 3D ).
The formation of blends containing DCH EO and DCH T also affects other physical properties of the resulting materials, in particular their viscosities, which can be gauged by their loss moduli (G″). To study these physical changes in more detail, we compared storage modulus or stiffness (G′) between 9 and its blends with 1 at 25 ºC and 40 ºC at 3 wt % total DCH concentration ( Figure 3E ). These data show that while G′ of the samples does not vary significantly above T G , the G′ of the blends are different from 9 in the viscous fluid state at 25 ºC, due to the incorporation of 1, which associates strongly at this temperature. DCH T loss moduli (G″), which are more sensitive to the liquid (i.e. viscous)
properties of the samples, show even greater differences between 9 and its blends with 1 ( Figure 3F ). At both 25 ºC and 40 ºC, the G″ values of the blends of 9 and 1 are much greater that those for pure 9, indicating significantly higher viscosity in the blends, especially at 25 ºC. Similar data for the blends at 2 wt % total DCH concentration ( Figure   3E , 3F) show these trends persist at different sample concentrations and thus allow precise and independent tuning of DCH T viscosity at 25 ºC, as well as stiffness above T G . It is also worth noting that, contrary to most PEO-polypeptide thermoresponsive hydrogels, T G in our samples vary only slightly with sample concentration (see Figure S5 ), which allows near independent tuning of hydrogel physical properties and T G . Overall, blending of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 20 increasing amounts of 1 with 9 resulted in DCH T with lower T G , as well as increased viscosity at 25 ºC. Increasing DCH T viscosity at ambient temperature can be beneficial for preparation of stable suspensions of cells or micro particles within DCH T below their T G (vide infra), which is not possible in pure 9 since it has a viscosity similar to water in the liquid state.
Loading and release of cargos in DCH T We have previously shown that hydrophilic and/or hydrophobic molecules can be loaded into ionic DCH and then released over time either in vitro or in vivo. 21, 26 Here, we studied the ability of DCH T to perform similar functions, evaluated how adjustment of DCH T or cargo properties affected release, and compared the results with those described earlier for ionic K 180 L 20 DCH. To examine the in vitro release dynamics of a protein from DCH T , we initially used the model protein lysozyme (m.w. 14.7 kDa) dissolved in different concentrations of an optimized DCH T formulation composed of 9 blended with 1 in an equimolar ratio, i.e. 9+1 (1:1) ( Figure 4A ).
Samples were prepared in PBS buffer, placed into dialysis cassettes and warmed to 37 ºC to trigger gelation, and then suspended in a large reservoir of PBS at 37 ºC. PBS media was used instead of water for these experiments to better mimic physiological conditions. Sampling of the dialyzate at different time intervals allowed measurement of released lysozyme concentrations over time, and these data were fit as described previously. concentration on release of model hydrophobic molecule cholesterol. All release studies conducted in PBS buffer at 37 °C.
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Since charged proteins are expected to interact strongly with ionic DCH (i.e.
K 180 L 20 ) via polyion complexation, 26 we also studied how overall protein charge affected their rate of release from DCH T . In this study, proteins of similar size, but different overall charge at pH 7 were prepared by chemical modification of lysozyme. We converted the majority of cationic ammonium groups in native "cationic" lysozyme (isoelectric point (pI) of 11.4) to either anionic carboxylate or neutral acetamide groups, by reaction with excess succinic anhydride or acetic anhydride, respectively, using well characterized methods. 27, 28 The carboxylate modification yields an "anionic" lysozyme (reported pI 4.5), 27 and acetamide modification yields a "neutral" lysozyme (reported pI 10), 28 both of which were found to have good water solubility in PBS media with no signs of aggregation over time.
The different overall charges present on these cationic, anionic, and neutral test proteins were found to strongly affect their rates of release from cationic K 180 L 20 DCH ( Figure 4C ).
The slow release of the anionic protein and the fast release of the cationic protein can be explained by polyionic interactions with these highly cationic polyelectrolyte DCH. 26 With non-ionic DCH T , the overall charges of the test proteins had no significant effect on their rates of release ( Figure 4D ), with cationic, anionic and neutral lysozymes all releasing at essentially the same rates. These data show that with non-ionic DCH T , rates of protein release are predominantly controlled by gel porosity and protein molecular weight, and their non-ionic nature allows release rates to be decoupled from overall charges present on different cargos.
The ability to dissolve and release hydrophobic therapeutic molecules is an attractive feature of traditional DCH that utilizes the hydrophobic segments of the polypeptides as reservoirs for these compounds. 21 However, DCH T differ from other DCH since they incorporate hydrophilic E P1 and E P2 components in their thermoresponsive domains that only become hydrophobic above T G . As such, we wanted to test if DCH T were also able to dissolve and provide prolonged release of hydrophobic molecules similar to our previously studied ionic DCH. 21 We have shown that cholesterol is a suitable test molecule for such studies, and now found that cholesterol is readily dissolved in 3 wt. % DCH T 9+1 (1:1) up to concentrations of 1.0 wt. % in DI water, which is lower than that found for K 180 L 20 DCH ( Figure 4E ). It is particularly noteworthy that the amount of cholesterol solubilized by DCH T is substantially greater than the amount soluble in water 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 ( Figure 1 samples 13,14) . These samples were prepared since we have shown that A based hydrophobic segments in DCH are more effective than L segments for solubilization of hydrophobic molecules. 21 Samples 13 and 14 were both found to behave as DCH T that are liquids at 25 ºC and transform to rigid hydrogels at ca. 37 ºC. With samples 13 and 14 at 3 wt. % in DI water, we found that cholesterol is readily dissolved up to concentrations of 1.5 and 3.0 wt. %, respectively ( Figure 4E ). These loading capacities are comparable with those previously found for ionic DCH, and show that DCH T can be tuned to retain advantageous capacity to dissolve hydrophobic molecules while also incorporating thermoresponsive properties.
Once dissolved in DCH T 9+1 (1:1), cholesterol (1.0 wt. %) was found to be released over time when the hydrogels were placed in constant volume dialysis cassettes and dialyzed against PBS buffer containing BSA at 37 ºC, which is above the T G for these samples. BSA was added to the dialyzate to capture released cholesterol, which would otherwise precipitate in the aqueous media. 21 Cholesterol release from different concentration DCH T 9+1 (1:1) samples was monitored over time, and in all cases ca. 65-90% of the loaded cholesterol was released into the dialysate over a period of days, with the remainder still encapsulated in the DCH ( Figure 4F ). Similar to results previously obtained for ionic DCH, 21 increasing the DCH T carrier concentration resulted in slower release of cholesterol, which can be advantageous for avoiding a "burst" type release of cargo. Overall, these data show that the many adjustable parameters available within DCH T can be used to predictably tune both loading capacity and release profiles of hydrophobic molecules in these hydrogels. Figure 5A ) and incubated at 37 ºC, which is above the T G for this DCH T . After 24 hours, cell viability was measured using the MTS assay relative to MSC viability in media only ( Figure 5B ).
Cationic K 180 L 20 DCH was highly toxic to fully immersed and suspended MSCs, consistent with earlier studies using HeLa cells (see Figure S1 ) and with the properties of cationic polymers in general. 31, 32 In contrast, both 2% and 3% DCH T 9+1 ( 
Conclusions
In this study, we designed and developed non-ionic DCH, named DCH EO , and thermoresponsive DCH, named DCH T , and showed that these new DCH are useful tools for encapsulation and release of molecules and culture of cells in vitro. A critical design element for successful formation of DCH EO was the use of a racemic, non-ionic hydrophilic segment, i.e. (rac-E P2 ), that possesses a disordered chain conformation in water, which allows the block copolypeptides to assemble into structures to yield the desired hydrogels. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 25
We also incorporated thermoresponsive elements into DCH EO to yield DCH T , which were designed to undergo liquid to hydrogel transitions at predetermined temperatures between ambient room temperature at 22 ºC and body temperature at 37 ºC. A key innovation in successful development of DCH T was our use of statistical copolymerization of E P2 residues with helicogenic hydrophobic residues, e.g. leucine or alanine, to prepare thermoresponsive segments that adopted stable α-helical conformations. Our DCH T design takes full advantage of the α-helical thermoresponsive segments, which allow reversible hydrogel formation as well as facile tunability of different physical characteristics. In vitro experiments showed that DCH T retained the many advantageous features of our original ionic DCH, such as injectability, tunable stiffness and viscosity, as well as the ability to load and provide prolonged release of both hydrophilic and hydrophobic molecules. 18, 19, 21, 26 In addition, non-ionic DCH T exhibited good cytocompatibility by supporting the survival of suspended MSCs in vitro. Our findings show that our design of non-ionic DCH T yields numerous advantageous properties for experimental investigations and potential therapeutic strategies. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
